Current Study: A10

Purpose:
• The overall purpose for this study is to find out if the investigational study drug is
absorbed or eliminated differently in people with normal kidney function compared to
people with impaired kidney function. Another purpose is to assess the safety and
tolerability of the study medication in people with healthy to impaired kidney function.
• This study is for research purposes only and is not intended to treat your kidney
disease.

Method of Administration: Single subcutaneous injection

Investigator: Thomas Marbury, MD

To qualify:

• 18 to 75 years old
• Must have kidney impairment or disease
• May be seeing a nephrologist, have reduced kidney function, or low creatinine
clearance and taking medicine such as:
• Procrit®, Epogen®, or Aranesp® for low blood count
or
• PhosLo for high blood phosphorus

Length/Duration
• 1 eligibility screening visit
• 8 days and 7 nights in our research facility
• 4 follow-up visits

Location: 5055 South Orange Avenue, Orlando, FL 32809

Qualified participants will receive study medication, study related physical exams and
laboratory tests

Compensation: Qualified participants will be compensated up to $4,700 for study-related time and
procedures

Whom to Contact: Recruitment Department: 407-240-7876